1. Wilkins E, Wilson L, Wickramasinghe K, et al. European Cardiovascular Disease Statistics 2017. European Heart Network, Brussels, 2017.
Google Scholar2. Istituto Nazionale di Statistica (ISTAT). Anni 2003-2014. L'evoluzione della mortalità per causa: le prime 25 cause di morte, https://www.istat.it/it/files/2017/05/Report-cause-di-morte-2003-14.pdf (2017, accessed 03 August 2020).
Google Scholar3. Keys, A, Menotti, A, Aravanis, C, et al. The Seven Countries Study: 2289 Deaths in 15 years. Prev Med 1984; 13: 141–154.
Google Scholar | Crossref | Medline | ISI4. Palmieri, L, Donfrancesco, C, Giampaoli, S, et al. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: Results from the Progetto CUORE. Eur J Cardiovasc Prev Rehabil 2006; 13: 562–570.
Google Scholar | SAGE Journals5. Giampaoli, S, Palmieri, L, Panico, S, et al. Favorable cardiovascular risk profile (low risk) and 10-year stroke incidence in women and men: Findings from 12 Italian population samples. Am J Epidemiol 2006; 163: 893–902.
Google Scholar | Crossref | Medline | ISI6. Ursu, S, Pannozzo, F, Palmieri, L, et al. Cardiovascular diseases and cancer incidence in general population: Results from MATISS cohorts. Epidemiol Prev 2016; 40: 433–438.
Google Scholar | Medline7. Gianfragna, F, Veronesi, G, Tozzi, M, et al. and RoCAV Project Investigators . Prevalence of abdominal aortic aneurysms in the general population and in subgroups at high cardiovascular risk in Italy. Results of the RoCAV population based study. Eur J Vasc Endovasc Surg 2018; 55: 633–639.
Google Scholar | Crossref | Medline8. Cecchi, F, Olivotto, J, Betocchi, S, et al. The Italian registry for hypertrophic cardiomyopathy: A national survey. Am Heart J 2005; 150: 947–954.
Google Scholar | Crossref | Medline9. Corrao, G, Ghirardi, A, Ibrahim, B, et al. Burden of new hospitalization for heart failure: A population-based investigation from Italy. Eur J Heart Fail 2014; 16: 729–736.
Google Scholar | Crossref | Medline10. Di Carlo, A, Bellino, L, Consoli, D, et al. Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: The FAI Project. Europace 2019; 21: 1468–1475.
Google Scholar | Crossref | Medline11. Murray, CJ, Ezzati, M, Flaxman, AD, et al. GBD 2010: Design, definitions, and metrics. Lancet 2012; 380: 2063–2066.
Google Scholar | Crossref | Medline | ISI12. James SL, Abate D, Abate KH, et al. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators . Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1789–1858.
Google Scholar | Crossref | Medline13. Roth GA, Abate D, Abate KH, et al. GBD 2017 Causes of Death Collaborators . Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1736–1788.
Google Scholar | Crossref | Medline14. Kyu HH, Abate D, Abate KH, et al. GBD 2017 DALYs and HALE Collaborators . Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1859–1922.
Google Scholar | Crossref | Medline15. Stanaway JD, Ajshin A, Gakidou E, et al. GBD 2017 Risk Factor Collaborators . Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1923–1994.
Google Scholar | Medline16. Stevens, GA, Alkema, L, Black, RE, et al.; GATHER Working Group . Guidelines for accurate and transparent health estimates reporting: The GATHER statement. PLoS Med 2016; 13: e1002056.
Google Scholar | Crossref | Medline17. Roth GA, Johnson CO, Abate KH, et al. Global Burden of Cardiovascular Diseases Collaboration . The burden of cardiovascular diseases among US States, 1990–2016. JAMA Cardiol 2018; 3: 375–389.
Google Scholar | Crossref | Medline18. Naghavi M, Abajobir AA, Abbafati C, et al. GBD 2016 Causes of Death Collaborators . Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1151–1210.
Google Scholar | Crossref | Medline19. Prabhakaran D, Jeemon P, Sharma M, et al. India State-Level Disease Burden Initiative CVD Collaborators The changing patterns of cardiovascular diseases and their risk factors in the states of India: The Global Burden of Disease Study 1990–2016. Lancet Glob Health 2018; 6: e1339–e1351.
Google Scholar | Crossref | Medline20. Roth, GA, Johnson, C, Abajobir, A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 2017; 70: 1–25.
Google Scholar | Crossref | Medline21. Ferrario, M, Cesana, G, Vanuzzo, D, et al. Surveillance of ischaemic heart disease: Results from the Italian MONICA populations. Int J Epidemiol 2001; 30: S23–S29.
Google Scholar | Crossref | Medline22. Franzosi, MG, Santoro, E, De Vita, C, et al. Ten-year-follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction. Results of Gruppo per lo Studio della Sopravvivenza nell’Infarto-1 study. Circulation 1998; 98: 2659–2665.
Google Scholar | Crossref | Medline | ISI23. De Rosa, S, Polimeni, A, Sabatino, J, et al. Long term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: A meta-analysis. BMC Cardiovasc Disord 2017; 17: 240.
Google Scholar | Crossref | Medline24. SPRINT Research Group ; Wright, JT, Williamson, JD, Whelton, PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373: 2103–2116.
Google Scholar | Crossref | Medline | ISI25. LaRosa, JC, Grundy, SM, Waters, DD, et al.; Treating to New Targets (TNT) Investigators . Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425–1435.
Google Scholar | Crossref | Medline | ISI26. Williams, B, Mancia, G, Spiering, W, et al.; ESC Scientific Document Group . 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J 2018; 39: 3021–3104.
Google Scholar | Crossref | Medline27. Mach, F, Baigent, C, Catapano, AL, et al.; ESC Scientific Document Group . 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41: 11–188.
Google Scholar | Crossref28. Piepoli, MF, Hoes, AW, Agewall, S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol 2016; 23: NP1–NP96.
Google Scholar | SAGE Journals | ISI29. Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (CHRODIS) . Good practice in the field of health promotion and primary prevention: Italy Country Review, http://chrodis.eu/wp-content/uploads/2015/02/Italy-CHRODIS-final-draft_rivistoBD_DG.pdf (2015, accessed 12 May 2020).
Google Scholar30. Strazzullo, P, Cairella, G, Campanozzi, A, et al.; GIRCSI Working Group . Population based strategy for dietary salt intake reduction: Italian initiatives in the European framework. Nutr Metab Cardiovasc Dis 2012; 22: 161–166.
Google Scholar | Crossref | Medline31. World Health Organization (WHO). European Health Information Gateway. Health for All explorer. https://gateway.euro.who.int/en/hfa-explorer/ (accessed 23 September 2019).
Google Scholar32. Mostaza, JM, Lahoz, C, Salinero-Fort, MA, et al. Cardiovascular disease in nonagenarians: Prevalence and utilization of preventive therapies. Eur J Prev Cardiol 2019; 26: 356–364.
Google Scholar | SAGE Journals33. Istituto Nazionale di Statistica (ISTAT). Hospitalizations for acute care by citizenship, http://dati.istat.it/Index.aspx?QueryId=26589&lang=en (2017, accessed 25 September 2019).
Google Scholar34. The Medicines Utilisation Monitoring Centre. National report on medicines use in Italy. Year 2017. Rome: Italian Medicines Agency , 2018
Google Scholar35. Frieden, TR, Berwick, DM. The ‘Million Hearts’ initiative: Preventing heart attacks and strokes. N Engl J Med 2011; 365: e27.
Google Scholar | Crossref | Medline | ISI36. Starfield, B. Pathways of influence on equity in health. Soc Sci Med 2007; 64: 1355–1362.
Google Scholar | Crossref | Medline37. Murray, CJ, Kulkarni, SC, Ezzati, M. Understanding the coronary heart disease versus total cardiovascular mortality paradox: A method to enhance the comparability of cardiovascular death statistics in the United States. Circulation 2006; 113: 2071–2081.
Google Scholar | Crossref | Medline38. Abreu, A, Pesah, E, Supervia, M, et al. Cardiac rehabilitation availability and delivery in Europe: How does it differ by region and compare with other high-income countries?: Endorsed by the European Association of Preventive Cardiology. Eur J Prev Cardiol 2019; 26: 1131–1146.
Google Scholar | SAGE Journals | ISI